CLINICAL_TRIALS
trial_result
· 2010-08-30
Clinical Trial Update: TRUST Study: Raptiva ® in Hand & Foot Psoriasis [Phase 4]
Summary
Phase 4 trial update for Raptiva (efalizumab) in hand and foot psoriasis shows the study was terminated. Results were posted on 2010-08-30.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Chronic Plaque Psoriasis | Phase 4 | Status: TERMINATED | Results posted: 2010-08-30